Top Markets
Coin of the day
Jafron Biomedical Co.,Ltd. Jafron Biomedical Co.,Ltd.

Jafron Biomedical Co.,Ltd.

300529
Rank in Stocks #6735
Jafron Biomedical Co.,Ltd. engages in the research and development, production,... Jafron Biomedical Co.,Ltd. engages in the research and development, production, and sale of blood purification products for hemadsorption field worldwide. The company offers therapies for kidney, liver, and critical diseases, as well as poisoning. It also provides HA series disposable hemoperfusion cartridge; BS series disposable plasma bilirubin perfusion adsorption column; blood purification machine; and other products, such as JM hemodialyzer, DNA230, disinfectant, hemodialysis concentrate, resin bandage, online hemodialysis B powder bag/bucket, PGA absorbable suture with needle, syringe and infusion pumps. The company was founded in 1989 and is based in Zhuhai, China.
Share Price
$2.37
Market Cap
$1.89B
Change (1 day)
0.06%
Change (1 year)
-28.77%
Country
CN
Trade Jafron Biomedical Co.,Ltd. (300529)

Category

Earnings for Jafron Biomedical Co.,Ltd. (300529)
Earnings in 2026 TTM: 0
According to Jafron Biomedical Co.,Ltd. latest financial reports the company's current earnings are 0. In 2026 the company made an earning of 0, equal to its 2026 earnings that were of 0. The earnings displayed on this page are the earnings before interest and taxes or simply EBIT.
Earnings history for Jafron Biomedical Co.,Ltd. from 2026 to 2026
Earnings at the end of each year
Year Earnings Change
Not enough data for the provided dates.
Earnings for similar companies or competitors